Terms: = Lymphoma AND PTPN13, PTP1E, 5783, ENSG00000163629, PTPLE, PTPL1, PNP1, PTP-BAS, DKFZp686J1497, Q12923, FAP-1, PTP-BL
15 results:
1. Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia.
Thangavadivel S; Zhao Q; Epperla N; Rike L; Mo X; Badawi M; Bystry DM; Phelps MA; Andritsos LA; Rogers KA; Jones J; Woyach JA; Byrd JC; Awan FT
Clin Cancer Res; 2020 Dec; 26(23):6187-6195. PubMed ID: 32958702
[TBL] [Abstract] [Full Text] [Related]
2. A multi-institutional analysis of diffuse large B-cell lymphoma (DLBCL) treated with consolidative radiotherapy and the impact of cell-of-origin on outcomes.
Rajasooriyar C; Tey J; Wong LC; Poon M; Nandini R; Tham I; Vellayappan B
Radiol Oncol; 2019 Oct; 53(4):473-479. PubMed ID: 31652123
[TBL] [Abstract] [Full Text] [Related]
3. Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.
Hunter ZR; Xu L; Tsakmaklis N; Demos MG; Kofides A; Jimenez C; Chan GG; Chen J; Liu X; Munshi M; Gustine J; Meid K; Patterson CJ; Yang G; Dubeau T; Samur MK; Castillo JJ; Anderson KC; Munshi NC; Treon SP
Blood Adv; 2018 Nov; 2(21):2937-2946. PubMed ID: 30401751
[TBL] [Abstract] [Full Text] [Related]
4. Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
Ferreri AJ; Sassone M; Zaja F; Re A; Spina M; Rocco AD; Fabbri A; Stelitano C; Frezzato M; Rusconi C; Zambello R; Couto S; Ren Y; Arcari A; Bertoldero G; Nonis A; Scarfò L; Calimeri T; Cecchetti C; Chiozzotto M; Govi S; Ponzoni M
Lancet Haematol; 2017 Mar; 4(3):e137-e146. PubMed ID: 28219694
[TBL] [Abstract] [Full Text] [Related]
5. [Methylation Status of ptpl1 Gene in Non-Hodgkin's lymphoma Cells].
Wang WM; Wang J; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1596-600. PubMed ID: 26708878
[TBL] [Abstract] [Full Text] [Related]
6. Promoter hypermethylation of ptpl1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
[TBL] [Abstract] [Full Text] [Related]
7. 5-Azacitidine induces demethylation of ptpl1 and inhibits growth in non-Hodgkin lymphoma.
Wang W; Wang J; Li M; Ying J; Jing H
Int J Mol Med; 2015 Sep; 36(3):698-704. PubMed ID: 26133246
[TBL] [Abstract] [Full Text] [Related]
8. A phase I study of midostaurin and azacitidine in relapsed and elderly AML patients.
Cooper BW; Kindwall-Keller TL; Craig MD; Creger RJ; Hamadani M; Tse WW; Lazarus HM
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):428-432.e2. PubMed ID: 25776192
[TBL] [Abstract] [Full Text] [Related]
9. [Expression and Significance of ptpl1 in Hematological Malignancies].
Wang WM; Wang J; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1744-7. PubMed ID: 25543508
[TBL] [Abstract] [Full Text] [Related]
10. Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr-abl oncogene.
Huang W; Bei L; Eklund EA
Leuk Lymphoma; 2013 Mar; 54(3):619-30. PubMed ID: 22891763
[TBL] [Abstract] [Full Text] [Related]
11. Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies.
Wong A; Marrie TJ; Garg S; Kellner JD; Tyrrell GJ;
Epidemiol Infect; 2010 Dec; 138(12):1804-10. PubMed ID: 20429967
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.
Bernhard D; Skvortsov S; Tinhofer I; Hübl H; Greil R; Csordas A; Kofler R
Cell Death Differ; 2001 Oct; 8(10):1014-21. PubMed ID: 11598799
[TBL] [Abstract] [Full Text] [Related]
13. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
[TBL] [Abstract] [Full Text] [Related]
14. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/fap-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
[TBL] [Abstract] [Full Text] [Related]
15. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis.
Cuppen E; Nagata S; Wieringa B; Hendriks W
J Biol Chem; 1997 Nov; 272(48):30215-20. PubMed ID: 9374505
[TBL] [Abstract] [Full Text] [Related]
